Heart Disease News and Research

Latest Heart Disease News and Research

National Heart, Lung and Blood Institutes funds multi-year project

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) will receive $10 million over the next 6 years to find the genetic causes of congenital heart disease.

28 Oct 2009

Researchers find healthy dose of exercise good for lymphoma patients receiving chemotherapy

A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.

28 Oct 2009

Scientists explore genetic 'Prozac markers'; research may provide simple test for treating depression

Prozac works wonders for some depressed people, but not for others. In some cases, patients derive little benefit and at worst, it can lead to bizarre hallucinations and fits of rage. Researchers and doctors remain puzzled as to what causes the wide range of reaction to Prozac and similar antidepressants.

28 Oct 2009

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.

27 Oct 2009

BIOTRONIK launches its new, unified platform pacemaker series in Europe

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the European launch of its new, unified platform pacemaker series, Evia, and several new products to further strengthen its bradycardia portfolio.

27 Oct 2009

GE’s AgileTrac Asset Manager and Enterprise Capacity Management Solution adopted by Virtua Healthcare

Virtua and GE Healthcare announced today that they are collaborating to implement new solutions to help increase efficiencies, lower healthcare costs and improve patient care throughout the health system. Virtua is adopting GE’s AgileTracTM Asset Manager and Enterprise Capacity Management Solution, an automated workflow solution that allows healthcare staff to better track a patient’s inpatient experience, as well as manage the hospital’s assets, ultimately reducing costs and increasing patient satisfaction.

27 Oct 2009

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology developed from research at the university's Department of Biomedical Engineering.

27 Oct 2009

Regional Medical Center Anniston to implement Wolters Kluwer Health's ProVation MD software

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Regional Medical Center Anniston has selected its ProVation® MD software for Cardiology procedure documentation and coding. The Anniston, AL-based hospital will use the software to document and code cases at its three cardiac catheterization labs.

27 Oct 2009

Netpulse raises funds for development of its interactive entertainment platform

Netpulse, the only interactive media platform for fitness centers and active lifestyle consumers, announced today that it has secured $3.1 million in Series A funding led by Javelin Venture Partners with participation from DFJ Frontier.

27 Oct 2009

CryoLife granted FDA approval for BioFoam human clinical trial

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's Investigational Device Exemption (IDE) to conduct a human clinical trial for its BioFoam® Surgical Matrix protein hydrogel technology.

27 Oct 2009

Even one cigarette has serious adverse effects on young adults, says researcher

Even one cigarette has serious adverse effects on young adults, according to research presented by Dr. Stella Daskalopoulou at the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2009

Inverness Medical Innovations announces its financial results for the third-quarter

Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced its financial results for the quarter ended September 30, 2009.

27 Oct 2009

Helicos Biosciences reports operational highlights for the third quarter of 2009

Helicos BioSciences Corporation announced today its operational, technical and scientific highlights for the quarter ended September 30, 2009.

27 Oct 2009

Bioconnect Systems to present clinical study of Optiflow device at ASN Meeting in San Diego

Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect’s implant platform, the Optiflow™, enhances a surgeon’s ability to create precise vascular connections.

27 Oct 2009

PolyMedix completes second successful clinical study of PMX-60056

PolyMedix, Inc. (http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders, has completed a second successful clinical study of its anticoagulant reversing agent, PMX-60056.

27 Oct 2009

Eli Lilly receives access to GeneNews' osteoarthritis genomic biomarker program

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has entered into an agreement allowing Eli Lilly and Company (NYSE: LLY) select access to research from its osteoarthritis genomic biomarker program

27 Oct 2009

Smoking one cigarette can increase artery stiffness by 25% in young adults

27 Oct 2009

One in five young teens has high blood pressure; elevated cholesterol levels increasing at alarming rate

A seven-year ongoing study examining over 20,000 Canadian grade 9 students shows most already have at least one major risk factor for heart disease and stroke, Dr. Brian McCrindle told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2009

Excessive salt intake raises blood pressure and increases risk for heart disease and stroke

A move from a traditional diet to the sodium-laden Western diet is fuelling a spike in the blood pressure of the Inuit in Canada's North, Dr. Marie-Ludivine Chateau-Degat told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2009

Study reveals that adding ezetimibe to atorvastatin aids in reducing cholesterol

Edmonton - Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2009

Heart Disease News and Research

Latest Heart Disease News and Research

National Heart, Lung and Blood Institutes funds multi-year project

Researchers find healthy dose of exercise good for lymphoma patients receiving chemotherapy

Scientists explore genetic 'Prozac markers'; research may provide simple test for treating depression

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

BIOTRONIK launches its new, unified platform pacemaker series in Europe

GE’s AgileTrac Asset Manager and Enterprise Capacity Management Solution adopted by Virtua Healthcare

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Regional Medical Center Anniston to implement Wolters Kluwer Health's ProVation MD software

Netpulse raises funds for development of its interactive entertainment platform

CryoLife granted FDA approval for BioFoam human clinical trial

Even one cigarette has serious adverse effects on young adults, says researcher

Inverness Medical Innovations announces its financial results for the third-quarter

Helicos Biosciences reports operational highlights for the third quarter of 2009

Bioconnect Systems to present clinical study of Optiflow device at ASN Meeting in San Diego

PolyMedix completes second successful clinical study of PMX-60056

Eli Lilly receives access to GeneNews' osteoarthritis genomic biomarker program

Smoking one cigarette can increase artery stiffness by 25% in young adults

One in five young teens has high blood pressure; elevated cholesterol levels increasing at alarming rate

Excessive salt intake raises blood pressure and increases risk for heart disease and stroke

Study reveals that adding ezetimibe to atorvastatin aids in reducing cholesterol

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in